Northern Trust’s Kiora Pharmaceuticals KPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.9K Buy
+11,767
New +$29.6K ﹤0.01% 4326
2019
Q3
Sell
-3
Closed -$3K 4273
2019
Q2
$3K Hold
3
﹤0.01% 4246
2019
Q1
$4K Hold
3
﹤0.01% 4202
2018
Q4
$7K Hold
3
﹤0.01% 4221
2018
Q3
$5K Hold
3
﹤0.01% 4276
2018
Q2
$8K Hold
3
﹤0.01% 4260
2018
Q1
$6K Hold
3
﹤0.01% 4217
2017
Q4
$16K Buy
3
+1
+50% +$6.18K ﹤0.01% 4170
2017
Q3
$13K Buy
+2
New +$12.7K ﹤0.01% 4183

Other funds holding KPRX

Northern Trust's KPRX Position: Q2 2026 in Review

Northern Trust opened a new position in Kiora Pharmaceuticals (KPRX) in Q2 2026: 11,767 shares worth $30.9K. The stake represents ﹤0.01% of the portfolio and ranks #4326 among its holdings. This is a return to the name: Northern Trust previously reported a position in KPRX as recently as Q2 2019.

Northern Trust first reported a position in KPRX in Q3 2017 and has held it in 9 quarters since. 22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

  • Northern Trust held 11,767 shares of Kiora Pharmaceuticals worth $30.9K as of Q2 2026.
  • Kiora Pharmaceuticals was a new Northern Trust position in Q2 2026.
  • Kiora Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4326 holding.
  • Northern Trust first reported a position in Kiora Pharmaceuticals in Q3 2017 and has held it in 9 quarters since.
  • 22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.